[{"address1": "3891 Ranchero Drive", "address2": "Suite 150", "city": "Ann Arbor", "state": "MI", "zip": "48108", "country": "United States", "phone": "734 887 3903", "website": "https://www.esperion.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. The company's products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. The company has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Sheldon L. Koenig", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 1278804, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric J. Warren R.Ph.", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 718859, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin  Halladay M.B.A.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Glenn P. Brame", "age": 66, "title": "Chief Technical Operations Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin O. Looker J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 550350, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Tiffany  Aldrich M.B.A.", "title": "Associate Director of Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betty Jean Swartz", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 7, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.59, "open": 1.57, "dayLow": 1.56, "dayHigh": 1.7099, "regularMarketPreviousClose": 1.59, "regularMarketOpen": 1.57, "regularMarketDayLow": 1.56, "regularMarketDayHigh": 1.7099, "payoutRatio": 0.0, "beta": 1.042, "forwardPE": 8.45, "volume": 3108171, "regularMarketVolume": 3108171, "averageVolume": 5178969, "averageVolume10days": 3623310, "averageDailyVolume10Day": 3623310, "bid": 1.66, "ask": 1.73, "bidSize": 14, "askSize": 24, "marketCap": 331071008, "fiftyTwoWeekLow": 1.56, "fiftyTwoWeekHigh": 3.94, "priceToSalesTrailing12Months": 0.9962596, "fiftyDayAverage": 1.984, "twoHundredDayAverage": 2.1627, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 745939008, "profitMargins": -0.15571, "floatShares": 194420955, "sharesOutstanding": 195900000, "sharesShort": 28100794, "sharesShortPriorMonth": 33978548, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1426, "heldPercentInsiders": 0.00382, "heldPercentInstitutions": 0.66133004, "shortRatio": 6.49, "shortPercentOfFloat": 0.143, "impliedSharesOutstanding": 197035008, "bookValue": -1.894, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -51745000, "trailingEps": -0.28, "forwardEps": 0.2, "enterpriseToRevenue": 2.245, "enterpriseToEbitda": 13.7, "52WeekChange": -0.25, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 1.69, "targetHighPrice": 16.0, "targetLowPrice": 2.05, "targetMeanPrice": 6.63125, "targetMedianPrice": 5.0, "recommendationMean": 2.11111, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 144716992, "totalCashPerShare": 0.739, "ebitda": 54450000, "totalDebt": 559585024, "totalRevenue": 332313984, "revenuePerShare": 1.775, "grossProfits": 217475008, "revenueGrowth": 1.143, "grossMargins": 0.65443003, "ebitdaMargins": 0.16385001, "operatingMargins": -0.06395, "financialCurrency": "USD", "symbol": "ESPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Esperion Therapeutics, Inc.", "longName": "Esperion Therapeutics, Inc.", "corporateActions": [], "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1372253400000, "postMarketChangePercent": -0.556214, "postMarketPrice": 1.6806, "postMarketChange": -0.00940001, "regularMarketChange": 0.100000024, "regularMarketDayRange": "1.56 - 1.7099", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 5178969, "fiftyTwoWeekLowChange": 0.13000011, "fiftyTwoWeekLowChangePercent": 0.08333341, "fiftyTwoWeekRange": "1.56 - 3.94", "fiftyTwoWeekHighChange": -2.25, "fiftyTwoWeekHighChangePercent": -0.57106596, "fiftyTwoWeekChangePercent": -25.0, "earningsTimestamp": 1741086000, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1741093200, "earningsCallTimestampEnd": 1741093200, "isEarningsDateEstimate": true, "postMarketTime": 1741393616, "regularMarketTime": 1741381202, "exchange": "NGM", "messageBoardId": "finmb_28236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 6.2893095, "regularMarketPrice": 1.69, "epsTrailingTwelveMonths": -0.28, "epsForward": 0.2, "epsCurrentYear": -0.03333, "priceEpsCurrentYear": -50.70507, "fiftyDayAverageChange": -0.2939999, "fiftyDayAverageChangePercent": -0.14818545, "twoHundredDayAverageChange": -0.47269988, "twoHundredDayAverageChangePercent": -0.21856934, "priceToBook": -0.8922914, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.1 - Buy", "cryptoTradeable": false, "displayName": "Esperion Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]